Company / SG&A Expense
Globus Medical SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$1.2B
FY2025
5-year range
$354.8M / $1.2B
FY2021-FY2025
Trend
+20.1%
vs FY2024
Sector context
#40 of 158
Health Care
What the data says
Globus Medical's sg&a expense of $1.2B is higher than 75% of companies in the Health Care sector (FY2025). SG&A Expense has increased for 5 consecutive years, from $312M in FY2020 to $1.2B in FY2025.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of +30.5%. Top quartile in the Health Care sector.
Increased from $644M to $1.2B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +39.7%
- 5-Year CAGR
- +30.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 158This company $1.2B Sector average $175.9B
▼
-99.3% below sector average
Key checks
Key Insights
- Globus Medical's sg&a expense has grown for 5 consecutive years.
- 5-year CAGR of +30.5%, indicating consistent growth.
- In FY2025, sg&a expense increased 20.1% year-over-year.
- Ranks #40 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | +20.1% |
| FY2024 | $981.4M | +52.4% |
| FY2023 | $643.8M | +49.0% |
| FY2022 | $432.1M | +21.8% |
| FY2021 | $354.8M | +13.9% |
| FY2020 | $311.6M | -12.2% |
| FY2019 | $354.8M | +59.7% |
| FY2018 | $222.2M | -17.0% |
| FY2017 | $267.8M | +42.0% |
| FY2016 | $188.6M | +3.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026